Study Flags Possible DMT Risk for MS Patients Over Age 45 & Travel During COVID-19: Yes or No? episode artwork

EPISODE · Nov 27, 2020 · 11 MIN

Study Flags Possible DMT Risk for MS Patients Over Age 45 & Travel During COVID-19: Yes or No?

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses findings suggesting possible DMT risk for MS patients over age 45.Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the Ed Tobias column, MS Wire, on travel during Covid-19: Should we stay or should we go?=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.http://ChangesInRMS.com =====================================Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Nov 27, 2020

Embed this episode

NOW PLAYING

Study Flags Possible DMT Risk for MS Patients Over Age 45 & Travel During COVID-19: Yes or No?

0:00 11:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 11 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on November 27, 2020.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!